Skip to main content

Peer Review reports

From: Evaluation of patients treated with direct-acting anti-viral therapy for chronic hepatitis C and their risk of hepatocellular carcinoma in Hong Kong

Original Submission
14 Sep 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
11 Nov 2023 Reviewed Reviewer Report
13 Nov 2023 Reviewed Reviewer Report
26 Nov 2023 Author responded Author comments - VICTOR YUNG SIN CHOW
Resubmission - Version 4
26 Nov 2023 Submitted Manuscript version 4
29 Nov 2023 Author responded Author comments - VICTOR YUNG SIN CHOW
Resubmission - Version 5
29 Nov 2023 Submitted Manuscript version 5
3 Dec 2023 Author responded Author comments - VICTOR YUNG SIN CHOW
Resubmission - Version 6
3 Dec 2023 Submitted Manuscript version 6
4 Dec 2023 Author responded Author comments - VICTOR YUNG SIN CHOW
Resubmission - Version 7
4 Dec 2023 Submitted Manuscript version 7
11 Dec 2023 Reviewed Reviewer Report
12 Dec 2023 Reviewed Reviewer Report
Resubmission - Version 8
Submitted Manuscript version 8
Publishing
14 Dec 2023 Editorially accepted
25 Jan 2024 Article published 10.1186/s12876-023-03099-2

You can find further information about peer review here.

Back to article page